Triple-negative breast cancer (TNBC) is characterized by the lacking expression of the three markers that define breast cancer subtypes and treatment, namely, the estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER-2). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.